P24 The successful use of anakinra to control protracted immune reconstitution inflammatory syndrome in HIV associated tuberculosis: a report of two cases

Alexander J. Keeley(University of Sheffield), Rachel Tattersall(Sheffield Teaching Hospitals NHS Foundation Trust), Julia Greig(Guy's and St Thomas' NHS Foundation Trust), Vivak Parkash(Sheffield Teaching Hospitals NHS Foundation Trust), Paul Collini(Sheffield Teaching Hospitals NHS Foundation Trust), Anne Tunbridge(Sheffield Teaching Hospitals NHS Foundation Trust)
Lara D. Veeken
April 1, 2020
10.1093/rheumatology/keaa111.023
Cited by 0

Related Papers

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
|Cell Host & Microbe|2020|354
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
|The Lancet|2017|186
Supporting wellbeing in motor neurone disease for patients, carers, social networks, and health professionals: A scoping review and synthesis
|Palliative & Supportive Care|2017|34
Anakinra in the treatment of protracted paradoxical inflammatory reactions in HIV-associated tuberculosis in the United Kingdom: a report of two cases
|International Journal of STD & AIDS|2020|31
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial
|Trials|2012|27